GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (LTS:0IV3) » Definitions » Pre-Tax Income

Geron (LTS:0IV3) Pre-Tax Income : $-201.19 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Geron Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Geron's pretax income for the three months ended in Sep. 2024 was $-26.45 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-201.19 Mil. Geron's pretax margin was -93.55%.

During the past 13 years, Geron's highest Pretax Margin was 0.13%. The lowest was -77690.72%. And the median was -5714.53%.


Geron Pre-Tax Income Historical Data

The historical data trend for Geron's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Pre-Tax Income Chart

Geron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.55 -75.62 -116.11 -141.90 -184.13

Geron Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.81 -51.97 -55.39 -67.38 -26.45

Competitive Comparison of Geron's Pre-Tax Income

For the Biotechnology subindustry, Geron's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geron's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Geron's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Geron's Pre-Tax Income falls into.



Geron Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Geron's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-193.944+-0.023+-8.312+18.152+0
=-184.13

Geron's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.215+-0.063+-3.046+4.877+0
=-26.45

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-201.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Geron  (LTS:0IV3) Pre-Tax Income Explanation

Geron's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-26.447/28.271
=-93.55%

During the past 13 years, Geron's highest Pretax Margin was 0.13%. The lowest was -77690.72%. And the median was -5714.53%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Geron Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Geron's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Geron Business Description

Traded in Other Exchanges
Address
919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Geron Headlines

No Headlines